Dean Mitchell
Chairman bij PRAXIS PRECISION MEDICINES, INC.
Vermogen: 2 M $ op 29-02-2024
Profiel
Dean Jonathan Mitchell is a businessperson who has been the head of 12 different companies and presently is Independent Chairman at Praxis Precision Medicines, Inc. and Chairman at Kinnate Biopharma, Inc. He is also on the board of Precigen, Inc. and Theravance Biopharma, Inc.
In the past Mr. Mitchell was Chairman at Paxvax Corp., President, Chief Executive Officer & Director at Lux Biosciences, Inc., President-International Pharmaceuticals at Bristol Myers Squibb Co., Senior VP-Clinical Development & Product Strategy at GSK Plc, Chairman at Emergent Travel Health, Inc., Chairman for Covis Pharma Holdings BV, Executive Chairman for Covis Pharma Holdings SARL, President, Chief Executive Officer & Director at Guilford Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Zoetis Products LLC, President & Chief Executive Officer for Alpharma LLC, President of MGI GP, Inc. and Chairman for National Pharmaceutical Council.
Mr. Mitchell received an undergraduate degree from Coventry University and an MBA from Bayes Business School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PRECIGEN INC
0.20% | 14-03-2024 | 503 183 ( 0.20% ) | 774 902 $ | 29-02-2024 |
THERAVANCE BIOPHARMA INC
0.14% | 02-05-2023 | 70 018 ( 0.14% ) | 663 070 $ | 29-02-2024 |
30-09-2023 | 5 000 ( 0.04% ) | 233 900 $ | 29-02-2024 | |
KINNATE BIOPHARMA, INC.
-.--% | 12-06-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Dean Mitchell
Bedrijven | Functie | Begin |
---|---|---|
PRECIGEN, INC. | Director/Board Member | 01-03-2009 |
THERAVANCE BIOPHARMA, INC. | Director/Board Member | 01-06-2014 |
KINNATE BIOPHARMA INC. | Chairman | 09-09-2020 |
PRAXIS PRECISION MEDICINES, INC. | Chairman | 17-09-2020 |
Eerdere bekende functies van Dean Mitchell
Bedrijven | Functie | Einde |
---|---|---|
IMMUNOGEN, INC. | Director/Board Member | 12-02-2024 |
Covis Pharma Holdings SARL
Covis Pharma Holdings SARL Financial ConglomeratesFinance Covis Pharma Holdings SARL operates as a holding company with interests in manufacturing and distribution of specialty pharmaceutical products. The company was founded in 2011 and is headquartered in Luxembourg. | Chairman | 01-03-2020 |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Chairman | 01-03-2020 |
Paxvax Corp. | Chairman | 01-10-2018 |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Chairman | 01-10-2018 |
Opleiding van Dean Mitchell
Coventry University | Undergraduate Degree |
Bayes Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 7 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
IMMUNOGEN, INC. | Health Technology |
PRECIGEN, INC. | Health Technology |
GSK PLC | Health Technology |
THERAVANCE BIOPHARMA, INC. | Health Technology |
PRAXIS PRECISION MEDICINES, INC. | Health Technology |
KINNATE BIOPHARMA INC. | Health Technology |
Bedrijven in privébezit | 13 |
---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Health Technology |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
MGI GP, Inc. | |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Health Technology |
Covis Pharma Holdings SARL
Covis Pharma Holdings SARL Financial ConglomeratesFinance Covis Pharma Holdings SARL operates as a holding company with interests in manufacturing and distribution of specialty pharmaceutical products. The company was founded in 2011 and is headquartered in Luxembourg. | Finance |
Alpharma LLC | |
Paxvax Corp. |